123I-iobenguane for Myocardial Imaging for Risk Evaluation (MIRE): the AdreView Myocardial Imaging for Risk Stratification (ADMIRE) Implantable Cardioverter Defibrillator (ICD) trial.

29 April 2017 (12:50 - 13:05)
Organised by:
Congress Presentation Part of: Updates on risk guided stratification for primary prevention of sudden cardiac death in heart failure ICD therapy HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure